9 results · 19ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

SEDECAL X PLUS LP PLUS

FDA 510(k)
FDA Class 2 ·Radiology

Sklar®

FDA UDI
SKLAR CORPORATION·10649111060915·DUAL HEAD STETH 30" PURPLE

BROWNE METREX 1.8% GLUTARALDEHYDE INDICATOR FOR METRICIDE 28 AND METRICIDE PLUS 30 SOLUTIONS

FDA 510(k)
FDA Class 2 ·General Hospital

NATURAL-KNEE II SYSTEM-DURASUL TIBIAL INSERT AND DURASUL ALL-POLY PATELLA

FDA 510(k)
FDA Class 2 ·Orthopedic

OLECRANON OSTEOTOMY NAIL

FDA Adverse Event
Injury ·SYNTHES GMBH·Product code HSB·April 16, 2013

KNIGHTSTAR 330

FDA Adverse Event
Malfunction ·NELLCOR PURITAN BENNETT·Product code CBK·June 18, 2008

TERUMO ADVANCED PERFUSION SYSTEM 1

FDA Adverse Event
Malfunction ·TERUMO CARDIOVASCULAR SYSTEMS CORP·Product code DTQ·April 12, 2011

MOZAIK

FDA Adverse Event
Injury ·ISOTIS ORTHOBIOLOGICS INC.·Product code MQV·January 7, 2021

Integra Mozaik Putty 2.5cc, 5 cc, 10 cc Product Usage: The product is a bone graft substitute composed of collagen (Type 1) and ceramic (IP3-Tricalcium phosphate) matrix in putty and strip forms. The product is intended for use as a bone void filler to fill voids or gaps of the skeletal system in the extremities, spine. and pelvis not intrinsic to the stability of the bony structure. Integra Mozaik is also indicated for use in the treatment of surgically treated osseous defects or osseous defects created from traumatic injury to the bone. Following placement in the bone void or a defect Integra Mozaik is reabsorbed and replaced with bone during the healing process.

FDA Enforcement
Class II ·Terminated·Integra LifeSciences Corp.·June 20, 2012